Stugeron Cinnarizine 25mg 50 tabs

Stugeron Indications

– Supportive treatment of symptoms of labyrinthine disorders including vertigo, nausea, vomiting, tinnitus and nystagmus.

– Prevention of motion sickness.

– Prophylaxis of migraine.

– Supportive treatment of symptoms of cerebrovascular origin, including dizziness, tinnitus (tynitus), headache vascular origin, irritability, memory loss and inability to concentrate.

– Supportive treatment of symptoms of peripheral vascular disorders including Raynaud’s disease, acrocyanosis, intermittent claudication, trophic disorders and varicose ulcers, paresthesia, nocturnal cramps in the limbs, feeling cold in the extremities.

Contraindications

Hypersensitivity to the active substance or to any of the excipients of the drug.

Dosage & Administration

Adults and children over 12 years.

Cerebrovascular accident: 1 tablet 25 mg 3 times a day (75 mg / day).

Violation of peripheral blood 2-3 tablets of 25 mg 3 times a day (150-225 mg / day).

Imbalance: 1 tablet 25 mg 3 times a day (75 mg / day).

Motion sickness: 1 tablet of 25 mg half an hour before the trip; method can be repeated every 6 hours.

Children. Children aged 5-12 years half the recommended dose for adults.

Elderly patients. No available data.